These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6127863)

  • 21. Muscarinic receptor binding in the rat adrenal medulla.
    Kayaalp SO; Neff NH
    Eur J Pharmacol; 1979 Aug; 57(2-3):255-7. PubMed ID: 226376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chronic fluphenazine and clozapine elicit opposite changes in brain muscarinic receptor binding: implications for understanding tardive dyskinesia.
    Friedman E; Gianutsos G; Kuster J
    J Pharmacol Exp Ther; 1983 Jul; 226(1):7-12. PubMed ID: 6864552
    [No Abstract]   [Full Text] [Related]  

  • 23. Brain muscarinic cholinergic receptor binding in Roman high- and low-avoidance rats.
    Overstreet DH; Driscoll P; Martin JR; Yamamura HI
    Psychopharmacology (Berl); 1981; 72(2):143-5. PubMed ID: 6782603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly) on the binding of 3H-quinuclidinyl benzilate to striatal cholinergic muscarinic receptors.
    Das S; Matwyshyn GA; Bhargava HN
    Peptides; 1986; 7(1):21-5. PubMed ID: 2872660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of muscarinic and nicotinic binding sites in brain.
    Nordberg A; Larsson C
    Acta Physiol Scand Suppl; 1980; 479():19-23. PubMed ID: 6932800
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal muscarinic receptors are associated with substance P and somatostatin containing neurons.
    Ariano MA; Kenny SL
    Brain Res; 1989 Sep; 497(1):51-8. PubMed ID: 2477112
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Methacholine-induced decrease in the cholinergic muscarinic receptor content in the perfused working rat heart.
    Reinhardt RR; Roskoski R
    J Pharmacol Exp Ther; 1983 Jul; 226(1):135-9. PubMed ID: 6345753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of interaction between thyrotropin releasing hormone and its analogs with 3H-quinuclidinyl benzilate recognition sites in the rat striatum.
    Das S; Bhargava HN
    Neuropharmacology; 1985 Jul; 24(7):681-3. PubMed ID: 3927185
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and muscarinic cholinergic receptor affinities of 3-quinuclidinyl alpha-(alkoxyalkyl)-alpha-aryl-alpha-hydroxyacetates.
    Cohen VI; Gibson RE; Fan LH; De La Cruz R; Gitler MS; Hariman E; Reba RC
    J Med Chem; 1991 Oct; 34(10):2989-93. PubMed ID: 1920351
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional circadian variation of acetylcholine muscarinic receptors in the rat brain.
    Por SB; Bondy SC
    J Neurosci Res; 1981; 6(3):315-8. PubMed ID: 7299844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]spiperone and [3H]quinuclidinyl benzilate binding in striatal membranes from rats chronically treated with manganese chloride throughout development and for over two years.
    Leung TK; Lai JC; Lim L
    Gen Pharmacol; 1986; 17(1):121-3. PubMed ID: 3949146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional distribution of muscarinic cholinergic receptors in rat brain.
    Kobayashi RM; Palkovits M; Hruska RE; Rothschild R; Yamamura HI
    Brain Res; 1978 Oct; 154(1):13-23. PubMed ID: 698807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscarinic acetylcholine receptors of the small intestine and pancreas of the rat: distribution and the effect of vagotomy.
    Isaacs PE; Whitehead JS; Kim YS
    Clin Sci (Lond); 1982 Feb; 62(2):203-7. PubMed ID: 7053918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of septal lesions to alter muscarinic cholinergic or benzodiazepine binding sites in hippocampus of rat brain.
    Overstreet DH; Speth RC; Hruska RE; Ehlert F; Dumont Y; Yamamura HI
    Brain Res; 1980 Aug; 195(1):203-7. PubMed ID: 6105004
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quinuclidinyl benzilate binding in house fly heads and rat brain.
    Jones SW; Sumikawa K
    J Neurochem; 1981 Feb; 36(2):454-9. PubMed ID: 7463072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholinergic receptors of rat lymphocytes during adjuvant polyarthritis.
    Krzystyniak K; Ryzewski J; Maślinski W
    Biochim Biophys Acta; 1982 Oct; 691(2):341-4. PubMed ID: 7138864
    [No Abstract]   [Full Text] [Related]  

  • 39. Regional distribution of muscarinic acetylcholine receptors in the telencephalon of the pigeon (Columbia livia f. domestica).
    Wächtler K
    J Hirnforsch; 1985; 26(1):85-9. PubMed ID: 3989280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A unique regulatory profile and regional distribution of [3H]pirenzepine binding in the rat provide evidence for distinct M1 and M2 muscarinic receptor subtypes.
    Watson M; Yamamura HI; Roeske WR
    Life Sci; 1983 Jun; 32(26):3001-11. PubMed ID: 6688111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.